Morgan Stanley
VKTXW

Morgan Stanley’s Viking Therapeutics, Inc. VKTXW Stock Holding History

Morgan Stanley’s Portfolio VKTXW Stock Details VKTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,700
Closed -$46K – 7996
2021
Q1 		$46K Hold
9,700
– – ﹤0.01% 6389
2020
Q4 		$40K Buy
+9,700
New +$44.2K ﹤0.01% 6225

Morgan Stanley's VKTXW Position: Q2 2021 in Review

Morgan Stanley sold out of Viking Therapeutics, Inc. (VKTXW) in Q2 2021, closing a stake of 9,700 shares — an estimated $46K sold.

Morgan Stanley first reported a position in VKTXW in Q4 2020 and held it in 2 quarters. The position peaked at $46K in Q1 2021. 0 funds tracked by Wall St. Rank hold VKTXW as of Q2 2021.

  • Morgan Stanley reported no remaining Viking Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Morgan Stanley sold 9,700 Viking Therapeutics, Inc. shares in Q2 2021, an estimated $46K.
  • Morgan Stanley first reported a position in Viking Therapeutics, Inc. in Q4 2020 and held it in 2 quarters.
  • Morgan Stanley's Viking Therapeutics, Inc. position peaked at $46K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Viking Therapeutics, Inc. as of Q2 2021.

Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.